This study is in progress, not accepting new patients
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Summary
- Eligibility
- for females ages 18-100 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT01872260
- Phase
- Phase 1/2 Breast Cancer Research Study
- Study Type
- Interventional
- Participants
- About 256 people participating
- Last Updated